Healthcare
M&A Advisory
Pharmaceutical
Research
M&A Advisory
Lazard
Full Credential Description
Gilead Sciences. United States. Announced Date 15/09/2016. Closed Date 20/09/2016. Deal value: $5000m. Senior unsecured notes. Industry: Gilead Sciences is a biopharmaceutical company that focuses on the research, development, and commercialization of antiviral drugs and treatments.